HEADER LIGASE 12-JUL-18 6H22 TITLE CRYSTAL STRUCTURE OF MDM2 BOUND TO A STAPLED PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE MDM2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DOUBLE MINUTE 2 PROTEIN,HDM2,ONCOPROTEIN MDM2,RING-TYPE E3 COMPND 5 UBIQUITIN TRANSFERASE MDM2,P53-BINDING PROTEIN MDM2; COMPND 6 EC: 2.3.2.27; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: STAPLED PEPTIDE; COMPND 11 CHAIN: C, D; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MDM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS STAPLED PEPTIDE, INHIBITOR, E3-LIGASE, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR X.WANG,K.SHARMA,D.R.SPRING,M.HYVONEN REVDAT 3 11-SEP-19 6H22 1 JRNL REVDAT 2 28-AUG-19 6H22 1 JRNL REVDAT 1 31-JUL-19 6H22 0 JRNL AUTH K.SHARMA,A.V.STRIZHAK,E.FOWLER,X.WANG,W.XU,C.HATT JENSEN, JRNL AUTH 2 Y.WU,H.F.SORE,Y.H.LAU,M.HYVONEN,L.S.ITZHAKI,D.R.SPRING JRNL TITL WATER-SOLUBLE, STABLE AND AZIDE-REACTIVE STRAINED DIALKYNES JRNL TITL 2 FOR BIOCOMPATIBLE DOUBLE STRAIN-PROMOTED CLICK CHEMISTRY. JRNL REF ORG.BIOMOL.CHEM. V. 17 8014 2019 JRNL REFN ESSN 1477-0539 JRNL PMID 31418442 JRNL DOI 10.1039/C9OB01745C REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.06 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.310 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 14409 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 743 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.0759 - 3.4305 1.00 2895 151 0.1667 0.1865 REMARK 3 2 3.4305 - 2.7230 1.00 2785 156 0.2169 0.2502 REMARK 3 3 2.7230 - 2.3788 1.00 2715 155 0.2393 0.2685 REMARK 3 4 2.3788 - 2.1613 1.00 2736 148 0.2628 0.2906 REMARK 3 5 2.1613 - 2.0064 0.93 2535 133 0.3015 0.3706 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.590 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 1823 REMARK 3 ANGLE : 0.882 2475 REMARK 3 CHIRALITY : 0.032 268 REMARK 3 PLANARITY : 0.005 355 REMARK 3 DIHEDRAL : 14.577 715 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6H22 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-JUL-18. REMARK 100 THE DEPOSITION ID IS D_1200009857. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14472 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 72.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.11100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.73200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.1 M SODIUM MALONATE DIBASIC, 0.1 M REMARK 280 HEPES PH 7.0, 0.5% V/V JEFFAMINE ED-2003, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 292.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.20800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 22.56200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.09300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 22.56200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.20800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.09300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 12 REMARK 465 PRO A 13 REMARK 465 LEU A 14 REMARK 465 GLY A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 GLY B 12 REMARK 465 PRO B 13 REMARK 465 LEU B 14 REMARK 465 GLY B 15 REMARK 465 SER B 16 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ligand NH2 C 13 bound to SER C REMARK 800 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ligand NH2 D 13 bound to SER D REMARK 800 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE C 0 and LEU C 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide FL5 C 1001 and ALA C REMARK 800 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide FL5 C 1001 and ALA C REMARK 800 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE D 0 and LEU D 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide FL5 D 1001 and ALA D REMARK 800 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide FL5 D 1001 and ALA D REMARK 800 4 DBREF 6H22 A 17 108 UNP Q00987 MDM2_HUMAN 17 108 DBREF 6H22 B 17 108 UNP Q00987 MDM2_HUMAN 17 108 DBREF 6H22 C 0 13 PDB 6H22 6H22 0 13 DBREF 6H22 D 0 13 PDB 6H22 6H22 0 13 SEQADV 6H22 GLY A 12 UNP Q00987 EXPRESSION TAG SEQADV 6H22 PRO A 13 UNP Q00987 EXPRESSION TAG SEQADV 6H22 LEU A 14 UNP Q00987 EXPRESSION TAG SEQADV 6H22 GLY A 15 UNP Q00987 EXPRESSION TAG SEQADV 6H22 SER A 16 UNP Q00987 EXPRESSION TAG SEQADV 6H22 ALA A 69 UNP Q00987 GLU 69 CONFLICT SEQADV 6H22 ALA A 70 UNP Q00987 LYS 70 CONFLICT SEQADV 6H22 GLY B 12 UNP Q00987 EXPRESSION TAG SEQADV 6H22 PRO B 13 UNP Q00987 EXPRESSION TAG SEQADV 6H22 LEU B 14 UNP Q00987 EXPRESSION TAG SEQADV 6H22 GLY B 15 UNP Q00987 EXPRESSION TAG SEQADV 6H22 SER B 16 UNP Q00987 EXPRESSION TAG SEQADV 6H22 ALA B 69 UNP Q00987 GLU 69 CONFLICT SEQADV 6H22 ALA B 70 UNP Q00987 LYS 70 CONFLICT SEQRES 1 A 97 GLY PRO LEU GLY SER SER GLN ILE PRO ALA SER GLU GLN SEQRES 2 A 97 GLU THR LEU VAL ARG PRO LYS PRO LEU LEU LEU LYS LEU SEQRES 3 A 97 LEU LYS SER VAL GLY ALA GLN LYS ASP THR TYR THR MET SEQRES 4 A 97 LYS GLU VAL LEU PHE TYR LEU GLY GLN TYR ILE MET THR SEQRES 5 A 97 LYS ARG LEU TYR ASP ALA ALA GLN GLN HIS ILE VAL TYR SEQRES 6 A 97 CYS SER ASN ASP LEU LEU GLY ASP LEU PHE GLY VAL PRO SEQRES 7 A 97 SER PHE SER VAL LYS GLU HIS ARG LYS ILE TYR THR MET SEQRES 8 A 97 ILE TYR ARG ASN LEU VAL SEQRES 1 B 97 GLY PRO LEU GLY SER SER GLN ILE PRO ALA SER GLU GLN SEQRES 2 B 97 GLU THR LEU VAL ARG PRO LYS PRO LEU LEU LEU LYS LEU SEQRES 3 B 97 LEU LYS SER VAL GLY ALA GLN LYS ASP THR TYR THR MET SEQRES 4 B 97 LYS GLU VAL LEU PHE TYR LEU GLY GLN TYR ILE MET THR SEQRES 5 B 97 LYS ARG LEU TYR ASP ALA ALA GLN GLN HIS ILE VAL TYR SEQRES 6 B 97 CYS SER ASN ASP LEU LEU GLY ASP LEU PHE GLY VAL PRO SEQRES 7 B 97 SER PHE SER VAL LYS GLU HIS ARG LYS ILE TYR THR MET SEQRES 8 B 97 ILE TYR ARG ASN LEU VAL SEQRES 1 C 14 ACE LEU THR PHE ALA GLU TYR TRP ALA GLN LEU ALA SER SEQRES 2 C 14 NH2 SEQRES 1 D 14 ACE LEU THR PHE ALA GLU TYR TRP ALA GLN LEU ALA SER SEQRES 2 D 14 NH2 HET ACE C 0 3 HET NH2 C 13 1 HET ACE D 0 3 HET NH2 D 13 1 HET FL5 C1001 33 HET FL5 D1001 33 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP HETNAM FL5 12-(DIMETHYLAMINO)-3,10-DIETHYL-N,N,N-TRIMETHYL-3,10- HETNAM 2 FL5 DIHYDRODIBENZO[3,4:7,8]CYCLOOCTA[1,2-D:5,6-D']BIS([1, HETNAM 3 FL5 2,3]TRIAZOLE)-5-AMINIUM FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 NH2 2(H2 N) FORMUL 5 FL5 2(C25 H31 N8 1+) FORMUL 7 HOH *191(H2 O) HELIX 1 AA1 PRO A 20 GLU A 25 1 6 HELIX 2 AA2 LYS A 31 VAL A 41 1 11 HELIX 3 AA3 MET A 50 ARG A 65 1 16 HELIX 4 AA4 ASP A 80 GLY A 87 1 8 HELIX 5 AA5 GLU A 95 ARG A 105 1 11 HELIX 6 AA6 PRO B 20 GLU B 25 1 6 HELIX 7 AA7 LYS B 31 VAL B 41 1 11 HELIX 8 AA8 MET B 50 ARG B 65 1 16 HELIX 9 AA9 ASP B 80 GLY B 87 1 8 HELIX 10 AB1 GLU B 95 ARG B 105 1 11 HELIX 11 AB2 THR C 2 GLN C 9 1 8 HELIX 12 AB3 THR D 2 ALA D 8 1 7 HELIX 13 AB4 GLN D 9 ALA D 11 5 3 SHEET 1 AA1 2 LEU A 27 VAL A 28 0 SHEET 2 AA1 2 TYR A 48 THR A 49 -1 O TYR A 48 N VAL A 28 SHEET 1 AA2 2 ILE A 74 TYR A 76 0 SHEET 2 AA2 2 SER A 90 SER A 92 -1 O PHE A 91 N VAL A 75 SHEET 1 AA3 2 LEU B 27 VAL B 28 0 SHEET 2 AA3 2 TYR B 48 THR B 49 -1 O TYR B 48 N VAL B 28 SHEET 1 AA4 2 ILE B 74 TYR B 76 0 SHEET 2 AA4 2 SER B 90 SER B 92 -1 O PHE B 91 N VAL B 75 LINK C ACE C 0 N LEU C 1 1555 1555 1.33 LINK CB ALA C 4 C FL5 C1001 1555 1555 1.50 LINK CB ALA C 11 C15 FL5 C1001 1555 1555 1.49 LINK C SER C 12 N NH2 C 13 1555 1555 1.33 LINK C ACE D 0 N LEU D 1 1555 1555 1.33 LINK CB ALA D 4 C FL5 D1001 1555 1555 1.50 LINK CB ALA D 11 C15 FL5 D1001 1555 1555 1.49 LINK C SER D 12 N NH2 D 13 1555 1555 1.35 SITE 1 AC1 4 GLN A 24 HOH A 209 ALA C 11 SER C 12 SITE 1 AC2 3 GLN B 24 ALA D 11 SER D 12 SITE 1 AC3 5 HOH A 226 THR C 2 GLU C 5 TYR C 6 SITE 2 AC3 5 GLN C 9 SITE 1 AC4 17 LYS A 51 PHE A 55 MET A 62 HOH A 207 SITE 2 AC4 17 TYR B 76 PRO B 89 SER B 90 PHE B 91 SITE 3 AC4 17 ALA C 4 GLU C 5 ALA C 8 GLN C 9 SITE 4 AC4 17 LEU C 10 SER C 12 NH2 C 13 HOH C1104 SITE 5 AC4 17 HOH C1108 SITE 1 AC5 17 PHE A 55 MET A 62 HOH A 207 TYR B 76 SITE 2 AC5 17 PRO B 89 SER B 90 PHE B 91 THR C 2 SITE 3 AC5 17 PHE C 3 GLU C 5 TYR C 6 TRP C 7 SITE 4 AC5 17 ALA C 8 ALA C 11 HOH C1104 HOH C1108 SITE 5 AC5 17 HOH C1109 SITE 1 AC6 6 LYS A 36 THR D 2 GLU D 5 TYR D 6 SITE 2 AC6 6 GLN D 9 HOH D1107 SITE 1 AC7 17 TYR A 76 PRO A 89 SER A 90 PHE A 91 SITE 2 AC7 17 LYS B 51 PHE B 55 GLN B 59 HOH B 222 SITE 3 AC7 17 ALA D 4 GLU D 5 ALA D 8 GLN D 9 SITE 4 AC7 17 LEU D 10 SER D 12 NH2 D 13 HOH D1103 SITE 5 AC7 17 HOH D1108 SITE 1 AC8 17 TYR A 76 PRO A 89 SER A 90 PHE A 91 SITE 2 AC8 17 PHE B 55 GLN B 59 HOH B 222 THR D 2 SITE 3 AC8 17 PHE D 3 GLU D 5 TYR D 6 TRP D 7 SITE 4 AC8 17 ALA D 8 ALA D 11 HOH D1103 HOH D1108 SITE 5 AC8 17 HOH D1110 CRYST1 64.416 72.186 45.124 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015524 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013853 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022161 0.00000